Volta Inc.

Volta Inc. (NYSE: VLTA), relating to its proposed sale to Shell USA. Under the terms of the agreement, VLTA shareholders are expected to receive $0.86 in cash per share they own.

Calyxt, Inc.

Calyxt, Inc. (NASDAQ: CLXT), relating to its proposed merger with Cibus. Under the terms of the agreement, Cibus shareholders are expected to receive new shares of CLXT, with CLXT shareholders expected to own approximately 5% of the combined company.

Angion Biomedica Corp.

Angion Biomedica Corp. (NASDAQ: ANGN), relating to its proposed merger with Elicio Therapeutics. Under the terms of the agreement, Elicio shareholders are expected to receive new shares of ANGN, with ANGN shareholders expected to own approximately 34.5% of the combined company.

Golden Matrix Group, Inc.

Golden Matrix Group, Inc. (NASDAQ: GMGI), relating to its proposed merger with MeridianBet Group.

Duck Creek Technologies, Inc.

Duck Creek Technologies, Inc. (NASDAQ: DCT), relating to its proposed sale to Vista Equity Partners. Under the terms of the agreement, DCT shareholders are expected to receive $19.00 in cash per share they own.

Paya Holdings Inc.

Paya Holdings Inc. (NASDAQ: PAYA), relating to its proposed sale to Nuvei Corp. Under the terms of the agreement, PAYA shareholders are expected to receive $9.75 in cash per share they own.

Albireo Pharma, Inc.

Albireo Pharma, Inc. (NASDAQ: ALBO), relating to its proposed sale to Ipsen. Under the terms of the agreement, ALBO shareholders are expected to receive $42.00 in cash per share they own, plus one Contingent Value Right worth a deferred $10.00 per share.

CinCor Pharma, Inc

CinCor Pharma, Inc. (NASDAQ: CINC), relating to its proposed sale to AstraZeneca. Under the terms of the agreement, CINC shareholders are expected to receive $26.00 and one Contingent Value Right worth $10.00 in cash per share they own.

Amryt Pharma Plc

Amryt Pharma Plc (NASDAQ: AMYT), relating to its proposed sale to Chiesi Farmaceutici SpA. Under the terms of the agreement, AMYT shareholders are expected to receive $14.50 plus one Contingent Value Right of up to $2.50 per American Depositary Share they own.

IAA, Inc.

IAA, Inc. (NYSE: IAA), relating to its merger with Ritchie Bros. Auctioneers, Inc. Under the terms of the merger, IAA stockholders will receive $10.00 in cash and 0.5804 shares of Ritchie Bros. common stock per share they own.